BioStem Technologies
(OTC) BSEM
BioStem Technologies Financials at a Glance
Market Cap
$71.89M
Revenue (TTM)
$47.48M
Net Income (TTM)
$6.58M
EPS (TTM)
$-0.50
P/E Ratio
-8.79
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$4.42
Volume
30,835
Open
$4.39
Price
$4.42
Volume
30,835
Open
$4.39
Previous Close
$4.40
Daily Range
$4.36 - $4.49
52-Week Range
$3.09 - $15.45
Dividend
$0.00
Beta (Volatility)
0.50 (Low)
Price
$4.42
Volume
30,835
Open
$4.39
Previous Close
$4.40
Daily Range
$4.36 - $4.49
52-Week Range
$3.09 - $15.45
BSEM News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout BioStem Technologies
Industry
Pharmaceuticals
Sector
Health CareEmployees
32
CEO
Jason Matuszewski
Website
www.biostemtechnologies.comHeadquarters
Pompano Beach, FL 33064, US
BSEM Financials
Key Financial Metrics (TTM)
Gross Margin
93%
Operating Margin
-1%
Net Income Margin
-14%
Return on Equity
-16%
Return on Capital
-2%
Return on Assets
-13%
Earnings Yield
-11.38%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$71.89M
Shares Outstanding
16.34M
Volume
30.84K
Avg. Volume
65.82K
Financials (TTM)
Gross Profit
$44.22M
Operating Income
$689.15K
EBITDA
$469.73K
Operating Cash Flow
$9.94M
Capital Expenditure
$3.35M
Free Cash Flow
$6.59M
Cash & ST Invst.
$29.55M
Total Debt
$3.33M
BioStem Technologies Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$84.82M
-182.4%
Gross Profit
$85.28M
-185.9%
Gross Margin
1.01%
N/A
Market Cap
$71.89M
N/A
Market Cap/Employee
$35.94M
N/A
Employees
2
N/A
Net Income
$11.26M
-172.6%
EBITDA
$7.47M
-187.3%
Quarterly Fundamentals
Net Cash
$26.22M
+43.0%
Accounts Receivable
$9.87M
-90.7%
Inventory
$2.88M
+57.7%
Long Term Debt
$105.26K
-68.1%
Short Term Debt
$3.23M
-22.7%
Return on Assets
-13.15%
N/A
Return on Invested Capital
-1.76%
N/A
Free Cash Flow
$2.39M
-70.2%
Operating Cash Flow
$2.83M
-65.3%